Evidence map›Paper›PMID 38446810›Full record

ArticlePloS one2024

Vision transformer with masked autoencoders for referable diabetic retinopathy classification based on large-size retina image.

Yaoming Yang, Zhili Cai, Shuxia Qiu, Peng Xu

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yaoming YangCollege of Science, China Jiliang University, Hangzhou, Zhejiang, China.ORCID 0009-0005-1155-402X
Zhili CaiCollege of Science, China Jiliang University, Hangzhou, Zhejiang, China.
Shuxia QiuCollege of Science, China Jiliang University, Hangzhou, Zhejiang, China.
Peng XuCollege of Science, China Jiliang University, Hangzhou, Zhejiang, China.ORCID 0000-0002-4349-5627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer-aided diagnosis systems based on deep learning algorithms have shown potential applications in rapid diagnosis of diabetic retinopathy (DR). Due to the superior performance of Transformer over convolutional neural networks (CNN) on natural images, we attempted to develop a new model to classify referable DR based on a limited number of large-size retinal images by using Transformer. Vision Transformer (ViT) with Masked Autoencoders (MAE) was applied in this study to improve the classification performance of referable DR. We collected over 100,000 publicly fundus retinal images larger than 224×224, and then pre-trained ViT on these retinal images using MAE. The pre-trained ViT was applied to classify referable DR, the performance was also compared with that of ViT pre-trained using ImageNet. The improvement in model classification performance by pre-training with over 100,000 retinal images using MAE is superior to that pre-trained with ImageNet. The accuracy, area under curve (AUC), highest sensitivity and highest specificity of the present model are 93.42%, 0.9853, 0.973 and 0.9539, respectively. This study shows that MAE can provide more flexibility to the input image and substantially reduce the number of images required. Meanwhile, the pretraining dataset scale in this study is much smaller than ImageNet, and the pre-trained weights from ImageNet are not required also.

Indexed as

Diabetes MellitusDiabetic RetinopathyAbomasumAlgorithmsAnimalsArea Under CurveFundus Oculi

Identifiers

PMID38446810
PMCPMC10917269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.